EXHIBIT 10.7
EXECUTION COPY
STOCKHOLDERS AGREEMENT
By And Among
Eagle Test Systems, Inc.,
The Existing Stockholders
as defined herein
and
The Investors
as defined herein
Dated as of September 30, 2003
TABLE OF CONTENTS
Page
----
SECTION I. DEFINITIONS...................................................................... 2
1.1. Construction of Terms..................................................... 2
1.2. Terms Not Defined......................................................... 2
1.3. Number of Shares of Stock................................................. 2
1.4. Defined Terms............................................................. 2
SECTION II. REPRESENTATIONS AND WARRANTIES.................................................. 4
2.1. Representations and Warranties of the Stockholders........................ 4
SECTION III. RESTRICTIONS ON TRANSFER; RIGHT OF FIRST REFUSAL; CO-SALE PROVISIONS........... 5
3.1. Restrictions on Transfer.................................................. 5
3.2. Permitted Transfers....................................................... 5
3.3. Right of First Refusal.................................................... 6
3.4. Co-Sale Option of Investors............................................... 7
3.5. Contemporaneous Transfers................................................. 9
3.6. Effect of Prohibited Transfers............................................ 9
SECTION IV. RIGHTS AND OBLIGATIONS TO SELL.................................................. 10
4.1. Drag-Along Rights......................................................... 10
4.2. Procedure................................................................. 10
4.3. Bring-Along Rights........................................................ 10
SECTION V. RIGHTS TO PURCHASE............................................................... 10
5.1. Right to Participate in Certain Sales of Additional Securities............ 10
5.2. Eligible Stockholder Acceptance........................................... 11
5.3. Calculation of Pro Rata Allotment......................................... 11
5.4. Sale to Third Party....................................................... 11
5.5. Exceptions to Pre-Emptive Rights.......................................... 11
5.6. Assignment of Rights...................................................... 12
SECTION VI. ELECTION OF DIRECTORS........................................................... 12
6.1. Board Composition......................................................... 12
6.2. Assignment................................................................ 13
SECTION VII. COVENANTS OF THE COMPANY AND STOCKHOLDERS...................................... 13
7.1. Financial Statements, Reports, Etc........................................ 13
7.2. Corporate Existence....................................................... 14
7.3. Properties, Business Insurance............................................ 14
7.4. Key Person Insurance...................................................... 14
7.5. Directors and Officers' Insurance......................................... 14
7.6. Inspection, Consultation and Advice....................................... 14
7.7. Compensation of Investor Nominees......................................... 15
7.8. By-laws................................................................... 15
7.9. Employee Agreements....................................................... 15
7.10. Compliance with Laws, Payment of Taxes.................................... 15
7.11. Keeping of Records and Books of Account................................... 15
7.12. Indemnification........................................................... 16
7.13. Term...................................................................... 17
SECTION VIII. MISCELLANEOUS PROVISIONS...................................................... 17
8.1. Reliance.................................................................. 17
8.2. Legend on Securities...................................................... 17
8.3. Amendment and Waiver; Actions of the Board................................ 17
8.4. Notices................................................................... 18
8.5. Headings.................................................................. 18
8.6. Counterparts.............................................................. 18
8.7. Entire Agreement.......................................................... 18
8.8. Law Governing............................................................. 19
8.9. Successors and Assigns.................................................... 19
8.10. Dispute Resolution........................................................ 19
8.11. Remedies; Severability.................................................... 19
8.12. Termination............................................................... 19
8.13. Confidentiality........................................................... 19
EXHIBITS
Exhibit A - Form of Joinder Agreement
Exhibit B - Form of Employee Nondisclosure, Noncompetition and Assignment
Agreement
SCHEDULES
Schedule A - Existing Stockholders and Investors
STOCKHOLDERS AGREEMENT
THIS STOCKHOLDERS AGREEMENT (the "Agreement") is made as of September 30,
2003, by and among Eagle Test Systems, Inc., an Illinois corporation (the
"Company"), the individuals identified on Schedule A hereto as Existing
Stockholders (collectively, the "Existing Stockholders," and each individually,
an "Existing Stockholder"), the Persons identified on Schedule A hereto as
investors (each, an "Investor" and collectively, the "Investors"), and any other
shareholder or option holder who from time to time becomes party to this
Agreement by execution of a Joinder Agreement in substantially the form attached
hereto as Exhibit A (the "Joinder Agreement"). For the purpose of this
Agreement, a shareholder or an option holder who joins this Agreement pursuant
to a Joinder Agreement shall be included in the term "Existing Stockholder" or
"Investor" as specified in such Joinder Agreement. The Existing Stockholders and
the Investors are sometimes referred to herein collectively as the
"Stockholders," and each individually, a "Stockholder."
WHEREAS, on the date hereof, certain Investors (the "Series A Investors")
are purchasing shares of the Company's Series A Convertible Preferred Stock, par
value $.01 per share (the "Series A Preferred Stock"), pursuant to that certain
Stock Purchase Agreement dated as of the date hereof by and among the Company
and the Series A Investors (the "Purchase Agreement");
WHEREAS, the Existing Stockholders hold shares of the Company's common
stock, no par value (the "Common Stock"), as set forth in Schedule A of this
Agreement;
WHEREAS, on the date hereof, TA Subordinated Debt Fund, L.P. and TA
Investors, LLC (the "Lenders") will lend to the Company $30,000,000 pursuant to
the terms of that certain Note Purchase Agreement dated as of the date hereof
(the "Note Purchase Agreement"), in return for convertible subordinated
debentures (collectively, the "Convertible Subordinated Notes") which are
convertible into subordinated promissory notes of the Company (collectively, the
"Subordinated Notes") and warrants to acquire shares of Common Stock of the
Company (the "Warrants");
WHEREAS, it is a condition to the obligations of the Investors under the
Purchase Agreement and the Note Purchase Agreement that this Agreement be
executed by the parties hereto, and the parties are willing to execute this
Agreement and be bound by the provisions hereof;
WHEREAS, the parties hereto desire to agree upon the terms on which the
securities of the Company, now or hereafter outstanding and held by them, will
be held, transferred and voted.
NOW, THEREFORE, in consideration of the foregoing and the mutual covenants
and agreements hereinafter set forth, the parties hereto agree as follows:
SECTION I. DEFINITIONS
1.1. CONSTRUCTION OF TERMS. As used herein, the masculine, feminine or
neuter gender, and the singular or plural number, shall be deemed to be or to
include the other genders or number, as the case may be, whenever the context so
indicates or requires. Any reference to "day" shall mean a calendar day unless
indicated otherwise.
1.2. TERMS NOT DEFINED. Capitalized terms used herein and not otherwise
defined shall have the meanings ascribed to them in the Purchase Agreement.
1.3. NUMBER OF SHARES OF STOCK. Whenever any provision of this Agreement
calls for any calculation based on a number of shares of capital stock issued
and outstanding or held by a Stockholder, the number of shares deemed to be
issued and outstanding or held by that Stockholder, unless specifically stated
otherwise, as applicable, shall be the total number of shares of Common Stock
then issued and outstanding or owned by the Stockholder, as applicable, plus,
without duplication, the total number of shares of Common Stock issuable upon
the conversion of any convertible Preferred Stock or exercise of any warrants
then issued and outstanding or owned by such Stockholder, as applicable.
1.4. DEFINED TERMS. The following capitalized terms, as used in this
Agreement, shall have the meanings set forth below.
"Affiliate" shall mean with respect to any Person (as defined below), any
Person which, directly or indirectly, controls, is controlled by or is under
common control with such Person, including, without limitation, any partner,
officer, director, member or employee of such Person and, with respect to any
Person that is a venture capital fund, any investment fund now or hereafter
existing which is controlled by or under common control with one or more general
partners of such Person.
"Board of Directors" means the Board of Directors of the Company.
"Charter" means the Company's Amended and Restated Articles of
Incorporation in effect as of the date hereof, as amended from time to time.
"Code" means the Internal Revenue Code of 1986, as amended.
"Common Stock" means the Common Stock and any other common equity
securities issued by the Company, and any other shares of stock issued or
issuable with respect thereto (whether by way of a stock dividend or stock split
or in exchange for or upon conversion of such shares or otherwise in connection
with a combination of shares, recapitalization, merger, consolidation or other
corporate reorganization).
"Company" means Eagle Test Systems, Inc., an Illinois corporation and any
successors thereto.
"Competitor" means any one of Advantest America Corporation, Agilent
Technologies, Credence Systems Corporation, LTX Corporation, Nextest Systems
Corporation, NPTest Inc.,
2
Teradyne Inc. and Yokogawa Electric Corporation. The Company and/or the Existing
Stockholders may reasonably amend the foregoing list from time to time by
written notice delivered in accordance with Section 8.4.
"Equity Incentive Plan" means the Company's 2003 Stock Option and Grant
Plan, as amended from time to time.
"Exchange Act" means the Securities Exchange Act of 1934, as amended.
"Existing Stockholders" means those individuals identified as Existing
Stockholders on Schedule A hereto.
"Investors" means those Persons identified as investors on Schedule A
hereto.
"Majority Interest" means the Investors holding not less than a majority
of the outstanding Shares held by all of the Investors, calculated in accordance
with Section 1.3 hereof.
"Material Adverse Effect" means a material adverse effect on the assets,
liabilities, condition (financial or other), business or results of operations
of the Company (a "Material Adverse Effect").
"Person" means an individual, a corporation, an association, a joint
venture, a partnership, a limited liability company, an estate, a trust, an
unincorporated organization and any other entity or organization, governmental
or otherwise.
"Preferred Stock" means the Redeemable Preferred Stock and the Series A
Convertible Preferred Stock, together with any shares issued or issuable with
respect thereto (whether by way of a stock dividend or stock split or in
exchange for or in replacement of such shares or otherwise in connection with a
combination of shares, recapitalization, merger, consolidation or other
corporate reorganization).
"Proceeding" means any complaint, lawsuit or similar legal action filed in
any court, any investigation, formal or informal, by any Person, regulatory or
self-regulatory authority.
"Qualified Public Offering" has the meaning set forth in the Charter.
"Redeemable Preferred Stock" means the Company's Redeemable Preferred
Stock, par value $.01 per share.
"Securities Act" means the Securities Act of 1933, as amended.
"Series A Convertible Preferred Stock" means the Company's Series A
Convertible Preferred Stock, par value $.01 per share.
"Shares" means, at any time, shares of (i) Common Stock, (ii) Preferred
Stock, and (iii) any other equity securities (including the Warrants) now or
hereafter issued by the Company, together with any options thereon and any other
shares of stock issued or issuable
3
with respect thereto (whether by way of a stock dividend, stock split or in
exchange for or upon conversion of such shares or otherwise in connection with a
combination of shares, recapitalization, merger, consolidation or other
corporate reorganization). At all times, the number of Shares deemed issued and
outstanding or held or to be voted by any Stockholder shall be calculated in
accordance with Section 1.3.
"Stockholders" means, collectively, the Investors and the Existing
Stockholders.
"Third Party Buyer" means any Person who, immediately prior to the
contemplated transaction, (i) is not a Person who directly or indirectly owns in
excess of 5% of the outstanding Shares (a "5% Owner"), (ii) is not controlling,
controlled by or under common control with any such 5% Owner, (iii) is not the
spouse or descendant (by birth or adoption) of any such 5% Owner or a trust for
the benefit of such 5% Owner and/or such other Persons, and (iv) is neither a
portfolio company of any such 5% Owner nor a Subsidiary of any portfolio company
of any such 5% Owner. As used in this definition, "control" (including, with its
correlative meanings, "controlled by" and "under common control with") shall
have the meaning given to such term in the definition of "Affiliate."
"Transaction Documents" means the Agreement, the Purchase Agreement, the
Note Purchase Agreement, the Convertible Subordinated Notes, the Subordinated
Notes, the Warrants and the Registration Rights Agreement, including all
exhibits and schedules hereto.
"Transfer" means any direct or indirect transfer, donation, sale,
assignment, pledge, hypothecation, grant of a security interest in or other
disposal or attempted disposal of all or any portion of a security, any interest
or rights in a security, or any rights under this Agreement. "Transferred" means
the accomplishment of a Transfer, and "Transferee" means the recipient of a
Transfer.
SECTION II. REPRESENTATIONS AND WARRANTIES
2.1. REPRESENTATIONS AND WARRANTIES OF THE STOCKHOLDERS. Each of the
Stockholders, individually and not jointly, hereby represents, warrants and
covenants to the Company and the other Stockholders as follows: (a) such
Stockholder has full authority, power and capacity to enter into this Agreement
and perform its obligations hereunder; (b) this Agreement constitutes the valid
and binding obligation of such Stockholder enforceable against him in accordance
with its terms, except: (i) as limited by applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application affecting
enforcement of creditors' rights generally, (ii) as limited by laws relating to
the availability of specific performance, injunctive relief, or other equitable
remedies, and (iii) to the extent the indemnification provisions may be limited
by applicable federal or state securities laws; and (c) the execution, delivery
and performance by such Stockholder of this Agreement: (i) does not and will not
violate any laws, rules or regulations of the United States or any state or
other jurisdiction applicable to such Stockholder, or require such Stockholder
to obtain any approval, consent or waiver of, or to make any filing with, any
Person that has not been obtained or made; and (ii) does not and will not result
in a breach of, constitute a default under, accelerate any
4
obligation under or give rise to a right of termination of any indenture or loan
or credit agreement or any other material agreement, contract, instrument,
mortgage, lien, lease, permit, authorization, order, writ, judgment, injunction,
decree, determination or arbitration award to which such Stockholder is a party
or by which the property of such Stockholder is bound or affected, or result in
the creation or imposition of any mortgage, pledge, lien, security interest or
other charge or encumbrance on any of the assets or properties of such
Stockholder.
SECTION III. RESTRICTIONS ON TRANSFER; RIGHT OF FIRST REFUSAL; CO-SALE
PROVISIONS
3.1. RESTRICTIONS ON TRANSFER.
(a) Each Existing Stockholder agrees that such Existing
Stockholder will not, without the prior written consent of a Majority Interest,
Transfer all or any portion of the Shares now owned or hereafter acquired by
such Existing Stockholder, except in compliance with the conditions of this
Section III.
(b) Each Investor agrees that such Investor will not, without the
prior written consent of the Existing Stockholders holding a majority of the
outstanding Shares held by all of the Existing Stockholders (calculated in
accordance with Section 1.3 hereof), Transfer all or any portion of the Shares
now owned or hereafter acquired by such Investor to any Competitor unless such
Transfer is made in connection with (i) the termination or dissolution of such
Investor's partnership or investment fund and the Shares transferred comprise
less than 25% of the aggregate value of the securities being transferred to such
competitor pursuant to such termination or dissolution or (ii) any transaction
in which Leonard Foxman and the Foxman Family LLC are given the opportunity to
sell or transfer all of the Shares held by them as of the date of such proposed
Transfer.
3.2. PERMITTED TRANSFERS. Notwithstanding anything herein to the
contrary, the provisions of Sections 3.3 and 3.4 shall not apply to either of
the Transfers listed below, provided that in each case the Transferee shall have
entered into a Joinder Agreement in substantially the form attached hereto as
Exhibit A providing that all Shares so Transferred shall continue to be subject
to all provisions of this Agreement as if such Shares were still held by such
Existing Stockholder, except that no further Transfer shall thereafter be
permitted hereunder except in compliance with Sections 3.3 and 3.4:
(a) Transfers by any Existing Stockholder to the spouse, children
or siblings of such Existing Stockholder or to a trust or family limited
partnership for the exclusive benefit of any of them; and
(b) Transfers upon the death of any Existing Stockholder to such
Existing Stockholder's heirs, executors or administrators or to a trust under
such Existing Stockholder's will, or Transfers between such Existing Stockholder
and such Existing Stockholder's guardian or conservator.
5
Notwithstanding anything to the contrary in this Agreement or any failure by a
Transferee under this Section 3.2 to execute a Joinder Agreement, such
Transferee shall take any Shares so Transferred subject to all provisions of
this Agreement as if such Shares were still held by the Existing Stockholder
making such Transfer, whether or not they so agree in writing.
3.3. RIGHT OF FIRST REFUSAL. In the event that any of the Existing
Stockholders entertains a bona fide offer to purchase all or any portion of the
Shares held by such Existing Stockholder (a "Transaction Offer") from any other
Person (a "Buyer"), such Existing Stockholder (a "Transferring Stockholder")
may, subject to the provisions of Section 3.4 hereof, Transfer such Shares
pursuant to and in accordance with the following provisions of this Section 3.3:
(a) Offer Notice. The Transferring Stockholder shall cause the
Transaction Offer and all of the terms thereof to be reduced to writing and
shall promptly notify the Company and each of the Investors of such Transferring
Stockholder's desire to effect the Transaction Offer and otherwise comply with
the provisions of this Section 3.3 and, if applicable, Section 3.4 (such notice,
the "Offer Notice"). The Transferring Stockholder's Offer Notice shall
constitute an irrevocable offer to sell all but not less than all of the Shares
that are the subject of the Transaction Offer (the "Offered Shares") to the
Investors, on the basis described below, at a purchase price equal to the price
contained in, and on the same terms and conditions of, the Transaction Offer.
The Offer Notice shall be accompanied by a true copy of the Transaction Offer
(which shall identify the Buyer and all relevant information in connection
therewith).
(b) Investors' Option. At any time within thirty (30) days after
receipt by the Investors of the Offer Notice (the "Investor Option Period"),
each Investor or its Affiliates, including future funds that have affiliated but
not identical general partners, may elect to accept the offer to purchase with
respect to any or all of the Offered Shares and shall give written notice of
such election (the "Investor Acceptance Notice") to the Transferring Stockholder
and each Investor within the Investor Option Period, which notice shall indicate
the maximum number of Offered Shares that the Investor is willing to purchase,
including the number of Offered Shares it would purchase if one or more other
Investors do not elect to purchase their Pro Rata Fractions (as defined in
paragraph (c) below). The Transferring Stockholder shall notify the Investors
promptly if any Investor fails to offer to purchase all of its Pro Rata
Fraction. If the Investors collectively do not elect to purchase all of the
Offered Shares, the Offer Notice shall be deemed to have been rejected. If the
Investors collectively elect to purchase all of the Offered Shares, the Offer
Notice shall be deemed to have been accepted, and each Investor Acceptance
Notice shall constitute a valid, legally binding and enforceable agreement for
the sale and purchase of the Offered Shares covered by such Investor Acceptance
Notice subject to any necessary adjustments as provided in Section 3.3(c). The
closing for the purchase of Offered Shares by the Investors under this Section
3.3(b) shall take place within thirty (30) days following the expiration of the
Investor Option Period, at the offices of the Company or on such other date or
at such other place as may be agreed to by the Transferring Stockholder and such
Investors.
(c) Allocation of Offered Shares among Investors. If the Offer
Notice is deemed accepted, upon the expiration of the Investor Option Period,
the number of Offered
6
Shares to be purchased by each Investor shall be determined as follows: (i)
first, there shall be allocated to each Investor electing to purchase, a number
of Offered Shares equal to the lesser of (A) the number of Offered Shares as to
which such Investor accepted as set forth in its respective Investor Acceptance
Notice or (B) such Investor's Pro Rata Fraction (as defined below), and (ii)
second, the balance, if any, not allocated under clause (i) above, shall be
allocated to those Investors who within the Investor Option Period delivered an
Investor Acceptance Notice that set forth a number of Offered Shares that
exceeded their respective Pro Rata Fractions, in each case on a pro rata basis
in proportion to the number of Shares held by each such Investor up to the
amount of such excess. An Investor's Pro Rata Fraction shall be equal to the
product obtained by multiplying the total number of Offered Shares by a
fraction, the numerator of which is the total number of Shares owned by such
Investor (other than any shares of Redeemable Preferred Stock), and the
denominator of which is the total number of Shares held by all Investors (other
than any shares of Redeemable Preferred Stock), in each case calculated as of
the date of the Offer Notice.
(d) Valuation of Property. In the event that the price set forth
in the Offer Notice is stated in consideration other than cash or cash
equivalents, the Transferring Stockholder, the Company and a Majority Interest
shall mutually determine the fair market value of such consideration, reasonably
and in good faith, and the Investors may effect their purchase under this
Section 3.3 by payment of such fair market value in cash or cash equivalents.
(e) Sale to Third Party. In the event that the Investors do not
elect to exercise the rights to purchase under this Section 3.3 with respect to
all of the Offered Shares proposed to be sold, the Transferring Stockholder may
sell all of the Offered Shares to the Buyer on the terms and conditions set
forth in the Offer Notice, subject to the provisions of Section 3.4. Promptly
after such Transfer, the Transferring Stockholder shall notify the Company and
the Investors of the consummation thereof and shall furnish such evidence of the
completion and time of completion of the Transfer and of the terms thereof as
may reasonably be requested by a Majority Interest. Prior to the effectiveness
of any Transfer to a Buyer hereunder, such Buyer shall have entered into a
Joinder Agreement in substantially the form attached hereto as Exhibit A, and
such Buyer shall have all the rights and obligations hereunder as if such Buyer
were an Existing Stockholder. If the Transferring Stockholder's sale to a Buyer
is not consummated in accordance with the terms of the Transaction Offer on or
before sixty (60) calendar days after the latest of: (i) the expiration of the
Investor Option Period, (ii) the expiration of the Co-Sale Election Period set
forth in Section 3.4 below, if applicable, and (iii) the satisfaction of all
governmental approval or filing requirements, the Transaction Offer shall be
deemed to lapse, and any Transfers of Shares pursuant to such Transaction Offer
shall be in violation of the provisions of this Agreement unless the
Transferring Stockholder sends a new Offer Notice and once again complies with
the provisions of this Section 3.3 with respect to such Transaction Offer or
such lapse is waived in writing by a Majority Interest.
3.4. CO-SALE OPTION OF INVESTORS. In the event that the Investors do not
exercise their rights under Section 3.3 with respect to all of the Offered
Shares proposed to be so Transferred by the Transferring Stockholder in
connection with a Transaction Offer, the Transferring
7
Stockholder may Transfer such Offered Shares to a Buyer only pursuant to and in
accordance with the following provisions of this Section 3.4:
(a) Co-Sale Notice. As soon as practicable following the
expiration of the Investor Option Period, and in no event later than five (5)
days thereafter, the Transferring Stockholder shall provide notice to each of
the Investors (the "Co-Sale Notice") of its right to participate in the
Transaction Offer on a pro rata basis with the Transferring Stockholder (the
"Co-Sale Option"). To the extent one or more Investors exercise their Co-Sale
Option in accordance with this Section 3.4, the number of Shares that the
Transferring Stockholder may Transfer in the Transaction Offer shall be
correspondingly reduced.
(b) Investor Acceptance. Each of the Investors shall have the
right to exercise its Co-Sale Option by giving written notice of such intent to
participate (the "Co-Sale Acceptance Notice") to the Transferring Stockholder
within ten (10) days after receipt by such Investor of the Co-Sale Notice (the
"Co-Sale Election Period"). Each Co-Sale Acceptance Notice shall indicate the
maximum number of Shares subject thereto that the Investor wishes to sell,
including the number of Shares it would sell if one or more other Investors do
not elect to participate in the sale on the terms and conditions stated in the
Offer Notice. Any Investor holding Preferred Stock shall be permitted to sell to
the relevant Buyer in connection with any exercise of the Co-Sale Option, at its
option, (i) shares of Common Stock acquired upon conversion of such Preferred
Stock, (ii) an option to acquire Common Stock when such Investor receives the
same upon conversion of such Preferred Stock, with the same effect as if Common
Stock were being conveyed, or (iii) shares of Preferred Stock, provided, that in
the case of the sale of shares of Preferred Stock, the Buyer shall pay for each
such share the relevant price per share of the underlying shares of Common
Stock.
(c) Allocation of Shares. Each Investor shall have the right to
sell a portion of its Shares pursuant to the Transaction Offer that is equal to
or less than the product obtained by multiplying the total number of Shares
available for sale to the Buyer subject to the Transaction Offer by a fraction,
the numerator of which is the total number of Shares owned by such Investor and
the denominator of which is the total number of Shares held by all Investors and
the Transferring Stockholder, in each case as of the date of the Offer Notice,
subject to increase as hereinafter provided. In the event any Investor does not
elect to sell the full amount of such Shares which such Investor is entitled to
sell pursuant to this Section 3.4, then any Investors who have elected to sell
Shares shall have the right to sell, on a pro-rata basis (based on the number of
Shares held by each such Investor) with any other Investors and up to the
maximum number of Shares stated in each such Investor's Co-Sale Acceptance
Notice, any Shares not elected to be sold by such Investor.
(d) Co-Sale Closing. Within ten (10) calendar days after the end
of the Co-Sale Election Period, the Transferring Stockholder shall promptly
notify each participating Investor of the number of Shares held by such Investor
that will be included in the sale and the date on which the sale contemplated by
the Transaction Offer will be consummated, which shall be no later than the
later of (i) sixty (60) calendar days after the end of the Co-Sale Election
Period and (ii) the satisfaction of any governmental approval or filing
requirements, if any. Each participating Investor may effect its participation
in any Transaction Offer hereunder by delivery
8
to the Buyer, or to the Transferring Stockholder for delivery to the Buyer, of
one or more instruments or certificates, properly endorsed for transfer,
representing the Shares it elects to sell pursuant thereto. The Transferring
Stockholder shall assign to each participating Investor, so much of its interest
in the agreement of sale as such Investor is entitled and each such Investor
shall assume, and hold the Transferring Stockholder harmless from, the
obligations under the agreement of sale with respect to the portion so assigned.
At the time of consummation of the Transaction Offer, the Buyer shall remit
directly to each participating Investor that portion of the sale proceeds to
which the participating Investor is entitled by reason of its participation with
respect thereto. No Shares may be purchased by the Buyer from the Transferring
Stockholder unless the Buyer simultaneously purchases from the participating
Investors all of the Shares that they have elected to sell pursuant to this
Section 3.4.
(e) Sale to Third Party. Any Shares held by a Transferring
Stockholder that are the subject of a Transaction Offer and that the
Transferring Stockholder desires to Transfer to a Buyer following compliance
with this Section 3.4, may be sold to such Buyer only during the period
specified in Section 3.4(d) and only on terms no more favorable to the
Transferring Stockholder than those contained in the Offer Notice. Promptly
after such Transfer, the Transferring Stockholder shall notify the Company and
the Investors of the consummation thereof and shall furnish such evidence of the
completion and time of completion of the Transfer and of the terms thereof as
may reasonably be requested by a Majority Interest. Prior to the effectiveness
of any Transfer to a Buyer hereunder, such Buyer shall have entered into a
Joinder Agreement in substantially the form attached hereto as Exhibit A, and
such Buyer shall have all the rights and obligations hereunder as if such Buyer
were an Existing Stockholder. In the event that the Transaction Offer is not
consummated within the period required by this Section 3.4 or the Buyer fails
timely to remit to each participating Investor its respective portion of the
sale proceeds, the Transaction Offer shall be deemed to lapse, and any Transfer
of Shares pursuant to such Transaction Offer shall be in violation of the
provisions of this Agreement unless the Transferring Stockholder sends a new
Offer Notice with respect to such Offered Shares and once again complies with
the provisions of Section 3.3 and Section 3.4 with respect to such Transaction
Offer or such lapse is waived in writing by a Majority Interest.
3.5. CONTEMPORANEOUS TRANSFERS. If two or more Existing Stockholders
propose concurrent Transfers that are subject to this Section III, then the
relevant provisions of Sections 3.3 and 3.4, as applicable, shall apply
separately to each such proposed Transfer.
3.6. EFFECT OF PROHIBITED TRANSFERS. If any Transfer by any Existing
Stockholder is made or attempted contrary to the provisions of this Agreement,
such purported Transfer shall be void ab initio; the Company, the Investors and
the other parties hereto shall have, in addition to any other legal or equitable
remedies which they may have, the right to enforce the provisions of this
Agreement by actions for specific performance (to the extent permitted by law);
and the Company shall have the right to refuse to recognize any Transferee of
any Existing Stockholder for any purpose.
9
SECTION IV. RIGHTS AND OBLIGATIONS TO SELL.
4.1. DRAG-ALONG RIGHTS. In the event of a Sale Event (as defined below),
each Existing Stockholder shall be obligated to and shall upon the written
request of a Majority Interest: (i) sell, transfer and deliver, or cause to be
sold, transferred and delivered, to the Third-Party Buyer a pro rata portion of,
his, her or its Shares on substantially the same terms applicable to the
Investors (including the terms of any indemnification); and (ii) execute and
deliver such instruments of conveyance and transfer and take such other action,
including voting such Shares in favor of any Sale Event proposed by a Majority
Interest and executing any purchase agreements, merger agreements, indemnity
agreements, escrow agreements or related documents, as such Investors or the
Third-Party Buyer may reasonably require in order to carry out the terms and
provisions of this Section 4.1 (the "Drag-Along Right").
For purposes of this Section IV, a "Sale Event" shall mean a bona fide
negotiated transaction in which a Majority Interest has determined (i) to sell
or otherwise dispose of all or substantially all of the assets of the Company,
or (ii) to sell sufficient capital stock of the Company to constitute a change
in control of the Company or (iii) to cause the Company to merge with or into or
consolidate with any non-Affiliate(s) of the Company.
4.2. PROCEDURE. Not less than thirty (30) days prior to the date proposed
for the closing of any Sale Event, the Investor shall give notice to the
Existing Stockholder, setting forth in reasonable detail the name or names of
the Third-Party Buyer, the terms and conditions of the Sale Event, including the
purchase price, and the proposed closing date and whether the Investor is
exercising the Drag-Along Right.
In furtherance of the provisions of this Section IV, upon request by a
Majority Interest, each Existing Stockholder shall execute a power-of-attorney
and proxy which (i) irrevocably appoints TA Associates, Inc., as its agent and
attorney-in-fact (the "Agent") (with full power of substitution) to execute all
agreements, instruments and certificates and take all actions necessary or
desirable to effectuate the Sale Event proposed hereunder; and (ii) grants to
the Agent a proxy to vote the Shares held by the Existing Stockholder in favor
of the Sale Event proposed hereunder.
4.3. BRING-ALONG RIGHTS. If in a Sale Event where the aggregate proceeds
to be received by the Investors on a per share basis is greater than or equal to
the original purchase price paid by such Investors with respect to any shares
being sold in such Sale Event, a Majority Interest does not exercise the
Drag-Along Right, any Existing Stockholder may, by delivering written notice to
the Investors and the Company within ten (10) days of its receipt of the notice
provided in Section 4.2, elect to sell his, her or its Shares as part of the
Sale Event on substantially the same terms applicable to the Investors.
SECTION V. RIGHTS TO PURCHASE
5.1. RIGHT TO PARTICIPATE IN CERTAIN SALES OF ADDITIONAL SECURITIES. The
Company agrees that it will not sell or issue or agree to sell or issue: (a) any
shares of capital stock of the Company, (b) securities convertible into or
exercisable or exchangeable for capital stock of the
10
Company or (c) options, warrants or rights carrying any rights to purchase
capital stock of the Company, unless the Company first submits a written notice
to each Stockholder identifying the terms of the proposed sale (including price,
number or aggregate principal amount of securities and all other material
terms), and offers to each Stockholder who is an "accredited investor," as such
term is defined in Rule 501 under the Securities Act (an "Eligible
Stockholder"), the opportunity to purchase its Pro Rata Allotment (as
hereinafter defined) of the securities (subject to increase for over-allotment
if some Eligible Stockholders do not fully exercise their rights) on terms and
conditions, including price, not less favorable than those on which the Company
proposes to sell such securities to a third party or parties (a "Pre-Emptive
Right Notice"). The Company's offer pursuant to this Section 5.1 shall remain
open and irrevocable for a period of twenty (20) days following receipt by the
Eligible Stockholders of such written notice.
5.2. ELIGIBLE STOCKHOLDER ACCEPTANCE. Each of the Eligible Stockholders
shall have the right to purchase its Pro Rata Allotment by giving written notice
of such intent to participate (the "Pre-emptive Right Acceptance Notice") to the
Company within twenty (20) days after receipt by such Eligible Stockholder of
the Pre-Emptive Right Notice (the "Pre-Emptive Right Acceptance Election
Period"). Each Pre-Emptive Right Acceptance Notice shall indicate the maximum
number of Shares subject thereto which the Eligible Stockholder wishes to buy,
including the number of Shares it would buy if one or more other Eligible
Stockholders do not elect to participate in the sale on the terms and conditions
stated in the Pre-Emptive Right Notice.
5.3. CALCULATION OF PRO RATA ALLOTMENT. Each Eligible Stockholder's "Pro
Rata Allotment" of such securities shall be based on the ratio which the number
of Shares owned by such Eligible Stockholder bears to all of the issued and
outstanding Shares as of the date of such written offer. If one or more Eligible
Stockholders do not elect to purchase their respective Pro Rata Allotment, each
of the electing Eligible Stockholders may purchase such Shares of such Eligible
Stockholders' allotments taking into account the maximum amount each is wishing
to purchase on a pro rata basis, based upon the relative holdings of Shares of
each of the electing Eligible Stockholders in the case of over-subscription.
5.4. SALE TO THIRD PARTY. Any securities so offered that are not
purchased by the Eligible Stockholders pursuant to the offer set forth in
Section 5.1 above, may be sold by the Company, but only on terms and conditions
not more favorable to the purchaser than those set forth in the notice to
Eligible Stockholders, at any time after five (5) days but within sixty (60)
days following the termination of the above-referenced 30-day period, but may
not be sold to any other Person or on terms and conditions, including price,
that are more favorable to the purchaser than those set forth in such offer or
after such 60-day period without renewed compliance with this Section V.
5.5. EXCEPTIONS TO PRE-EMPTIVE RIGHTS. Notwithstanding the foregoing, the
right to purchase granted under this Section V shall be inapplicable with
respect to: (i) the issuance of shares of Common Stock (as appropriately
adjusted for any stock split, combination, reorganization, recapitalization,
reclassification, stock distribution, stock dividend or similar event) issued or
issuable in connection with, or upon the exercise of, options or other awards
granted or to be granted to employees, officers or directors of the Company
pursuant to the
11
Company's equity incentive plans, including shares of Common Stock issued in
replacement of shares of such Common Stock repurchased or issuable upon the
exercise of any options to purchase shares of such Common Stock, to the extent
permitted under the equity incentive plans; (ii) securities issued as a result
of any stock split, stock dividend, reclassification or reorganization or
similar event with respect to the Shares; (iii) shares of Common Stock issued
upon conversion of, or as a dividend on, the Preferred Stock; (iv) securities
issued as consideration for the purchase of stock or assets in any acquisition,
merger, joint venture, partnership or other strategic alliance; (v) securities
issued in connection with any debt financing or refinancing of the Company or
(vi) securities issued with the approval of a Majority Interest provided that no
Investor or affiliate of any Investor is acquiring any of the securities in such
issuance.
5.6. ASSIGNMENT OF RIGHTS. Subject to Section 8.11 hereof, each Eligible
Stockholder shall have the right to assign its rights under this Section V to
any Transferee of such Eligible Stockholder's Shares, and shall further have the
right to assign and transfer such Eligible Stockholder's right to accept any
particular offer under Section 5.1 hereof, and any such Transferee shall be
deemed within the definition of an "Eligible Stockholder" for purposes of this
Section V.
SECTION VI. ELECTION OF DIRECTORS
6.1. BOARD COMPOSITION.
(a) For so long as the Existing Stockholders own at least five
percent (5%) of the outstanding capital stock of the Company, each Stockholder
agrees to vote all its shares of the Company's capital stock having voting power
(and any other shares over which it exercises voting control whether directly or
indirectly) in connection with the election of Directors and to take such other
actions as are necessary so as to elect and continue in the office two (2)
individuals nominated by a majority-in-interest of the Existing Stockholders,
who shall initially be Leonard Foxman and Theodore Foxman.
(b) For so long as the Existing Stockholders own at least five
percent (5%) of the outstanding capital stock of the Company, each Stockholder
agrees to vote all of its shares of the Company's capital stock having voting
power (and any other shares over which it exercises voting control whether
directly or indirectly) for the removal of any Director nominated by the
Existing Stockholders, as provided herein upon the request of a
majority-in-interest of the Existing Stockholders and for the election to the
Board of Directors of a substitute designated by such Existing Stockholders in
accordance with the provisions of Section 6.1(a).
(c) Each of the Stockholders agrees and acknowledges that pursuant
to the terms of the Charter, the holders of Series A Convertible Preferred Stock
are entitled to elect three Directors and to vote on an as converted basis with
all other holders of capital stock of the Company in all elections of the
Directors.
12
6.2. ASSIGNMENT. Each Investor and each Stockholder agrees, as a
condition to any transfer of its Shares to cause the transferee to agree to the
provisions of this Article VI, whereupon such transferee shall be subject to the
provisions hereof as an Investor or Stockholder, as applicable, in connection
with its ownership of the shares Transferred for purposes of this Article VI.
SECTION VII. COVENANTS OF THE COMPANY AND STOCKHOLDERS
The Company covenants and agrees with each of the Investors that:
7.1. FINANCIAL STATEMENTS, REPORTS, ETC. The Company shall furnish to
each Investor the following reports:
(a) Annual Financial Statements. Within one hundred and twenty
(120) days after the end of the fiscal year ended September 30, 2003 and
thereafter within ninety (90) days after the end of each fiscal year of the
Company, a consolidated balance sheet of the Company and its subsidiaries, if
any, as of the end of such fiscal year and the related consolidated statements
of income, shareholders' equity and cash flows for the fiscal year then ended,
prepared in accordance with generally accepted accounting principles and
certified by a firm of independent public accountants of recognized national
standing selected by the Board of Directors of the Company;
(b) Quarterly Financial Statements. Within forty-five (45) days
after the end of the first three fiscal quarters of each fiscal year, a
consolidated balance sheet of the Company and its subsidiaries, if any, and the
related consolidated statements of income, shareholders' equity and cash flows,
unaudited but prepared in accordance with generally accepted accounting
principles and certified by the Chief Financial Officer of the Company, such
consolidated balance sheet to be as of the end of such quarter and such
consolidated statements of income, shareholders' equity and cash flows to be for
such quarter and for the period from the beginning of the fiscal year to the end
of such quarter, in each case with comparative statements for the prior fiscal
year;
(c) Monthly Financial Statements. Within thirty (30) days after
the end of each month in each fiscal year (other than the last month in each
fiscal year), a consolidated balance sheet of the Company and its subsidiaries,
if any, and the related consolidated statements of income, shareholders' equity
and cash flows, unaudited but prepared in accordance with generally accepted
accounting principles (omitting footnotes) and certified by the Chief Financial
Officer of the Company, such consolidated balance sheet to be as of the end of
such month and such consolidated statements of income, shareholders' equity and
cash flows to be for such month and for the period from the beginning of the
fiscal year to the end of such month, in each case with comparative statements
for the prior fiscal year;
(d) Budget. No later than thirty (30) days prior to the start of
each fiscal year, consolidated capital and operating expense budgets, cash flow
projections and income and loss projections for the Company and its subsidiaries
in respect of such fiscal year, all itemized in
13
reasonable detail and prepared on a monthly basis, and, promptly after
preparation, any revisions to any of the foregoing;
(e) Accountant's Letters. Promptly following receipt by the
Company, each audit response letter, accountant's management letter and other
written report submitted to the Company by its independent public accountants in
connection with an annual or interim audit of the books of the Company or any of
its subsidiaries; and
(f) Other Information. Promptly, from time to time, such other
information regarding the business, prospects, financial condition, operations,
property or affairs of the Company and its subsidiaries as such Investor
reasonably may request.
7.2. CORPORATE EXISTENCE. The Company shall maintain and cause each of
its subsidiaries, if any, to maintain, their respective corporate existence.
7.3. PROPERTIES, BUSINESS INSURANCE. The Company shall obtain and
maintain and cause each of its subsidiaries, if any, to maintain as to their
respective properties and business, with financially sound and reputable
insurers, insurance against such casualties, contingencies and other risks and
hazards and of such types and in such amounts as is customary for companies
similarly situated.
7.4. KEY PERSON INSURANCE. The Company shall maintain, "key person" term
life insurance policies of at least $3,000,000 on the life of each of Leonard
Foxman and Jack Weimer which shall name the Company as beneficiary.
7.5. DIRECTORS AND OFFICERS' INSURANCE. The Company shall, as promptly as
practicable following the date hereof, obtain and maintain directors and
officers' liability insurance coverage on terms satisfactory to the Investor
Nominees of at least $10,000,000 per occurrence, to the fullest extent permitted
by law covering, among other things, violations of federal or state securities
laws. The Company shall use its reasonable best efforts prior to any initial
public offering of the Company's capital stock to increase its directors' and
officers' liability insurance to at least $15,000,000 per occurrence, including
coverage of claims under the Securities Act and the Exchange Act.
7.6. INSPECTION, CONSULTATION AND ADVICE. The Company shall permit and
cause each of its subsidiaries, if any, to permit each Investor and such persons
as each Investor may designate, at such Investor's expense, to visit and inspect
any of the properties of the Company and its subsidiaries, examine their books
and take copies and extracts therefrom, discuss the affairs, finances and
accounts of the Company and its subsidiaries with their officers, employees and
public accountants (and the Company hereby authorizes said accountants to
discuss with such Investor and such designees such affairs, finances and
accounts), and consult with and advise the management of the Company and its
subsidiaries as to their affairs, finances and accounts, all at reasonable times
and upon reasonable notice during normal business hours. The foregoing shall be
in addition to, and not in lieu of, the Investors' rights under applicable law.
14
7.7. COMPENSATION OF INVESTOR NOMINEES. The Company shall pay or promptly
reimburse in full each Investor Nominee for all of his reasonable out-of-pocket
expenses incurred in attending each meeting of the Board of Directors or any
Committee thereof. The Company shall also pay or promptly reimburse the
Investors for reasonable out-of-pocket expenses and costs incurred by them in
connection with their ongoing investment in the Company up to a maximum of
$40,000 per year.
7.8. BY-LAWS. The Company shall at all times maintain provisions in its
Bylaws and certificate of incorporation indemnifying all directors against
liability and absolving all directors from liability to the Company and its
shareholders to the maximum extent permitted under the laws of the State of
Illinois.
7.9. EMPLOYEE AGREEMENTS. The Company shall obtain, and shall cause its
subsidiaries, if any, to obtain, an Employee Nondisclosure, Noncompetition and
Assignment Agreement in substantially the form of Exhibit B attached hereto from
all current and future officers and employees and any consultants who will have
access to confidential information of the Company or any of its subsidiaries,
upon commencement of their employment or consulting arrangement by the Company
or any of its subsidiaries or for current officers, employees and consultants,
within a reasonable period of time after the date hereof. The Company shall not
amend, modify, terminate, waive or otherwise alter, in whole or in part, the
form of Employee Nondisclosure, Noncompetition and Assignment Agreement, now or
in the future in effect, without the approval of the Board of Directors,
including the Investor Nominees.
7.10. COMPLIANCE WITH LAWS, PAYMENT OF TAXES. The Company shall comply,
and cause each subsidiary to comply, with all applicable laws, rules,
regulations and orders, noncompliance with which could have a Material Adverse
Effect. The Company shall comply with all applicable federal and state
securities laws in connection with the offer, issuance, sale or redemption of
any shares of its capital stock. The Company will pay and discharge all lawful
Taxes as defined in the Purchase Agreement, assessments and governmental charges
or levies imposed upon it or upon its income or property before the same shall
become in default as well as all lawful claims for labor, materials and supplies
which, if not paid when due, might become a lien or charge upon its property or
any part thereof; provided, however, that the Company shall not be required to
pay and discharge any such Tax, assessment, charge, levy or claim so long as the
validity thereof is being contested by the Company in good faith by appropriate
proceedings and an adequate reserve therefore has been established on its books.
7.11. KEEPING OF RECORDS AND BOOKS OF ACCOUNT. The Company shall keep, and
cause each subsidiary, if any, to keep, adequate records and books of account,
in which complete entries will be made in accordance with generally accepted
accounting principles consistently applied, reflecting all financial
transactions of the Company and such subsidiary, and in which, for each fiscal
year, all proper reserves for depreciation, depletion, obsolescence,
amortization, taxes, bad debts and other purposes in connection with its
business shall be made.
15
7.12. INDEMNIFICATION.
(a) Without limitation of any other provision of this Agreement or
any other agreement connection herewith the Company agrees to defend, indemnify
and hold each Investor, its respective Affiliates and direct and indirect
partners (including partners of partners and stockholders and members of
partners), members, stockholders, directors, officers, employees and agents and
each person who controls any of them within the meaning of Section 15 of the
Securities Act, or Section 20 of the Exchange Act (collectively, the "Investor
Indemnified Parties" and, individually, an "Investor Indemnified Party")
harmless from and against any and all damages, liabilities, losses, Taxes,
fines, penalties, diminution in value, reasonable costs and expenses (including,
without limitation, reasonable fees of a single counsel representing all the
Investor Indemnified Parties or, if the representation of all the Investor
Indemnified Parties by the same counsel would be inappropriate under applicable
standards of professional conduct, then as many counsel as may be needed under
such standards of professional conduct to represent all of the Investor
Indemnified parties), as the same are incurred, of any kind or nature whatsoever
(whether or not arising out of third-party claims and including all amounts paid
in investigation, defense or settlement of the foregoing and consequential
damages) ("Losses") sustained or suffered by any such Investor Indemnified
Party, which may be based upon, relating to, arising out of, or by reason of any
third party or governmental claims relating in any way to such Investor
Indemnified Party's status as a security holder, creditor, director, agent,
representative or controlling person of the Company or otherwise relating to
such Investor Indemnified Party's involvement with the Company (including,
without limitation, any and all Losses under the Securities Act, the Exchange
Act or other federal or state statutory law or regulation, at common law or
otherwise, which relate directly or indirectly to the registration, purchase,
sale or ownership of any securities of the Company or to any fiduciary
obligation owed with respect thereto), including, without limitation, in
connection with any third party or governmental action or claim relating to any
action taken or omitted to be taken or alleged to have been taken or omitted to
have been taken by any Investor Indemnified Party as security holder, director,
agent, representative or controlling person of the Company or otherwise,
alleging so-called control person liability or securities law liability;
provided, however, that the Company will not be liable to any Investor
Indemnified Party to the extent that such Losses arise from and are based on (A)
an untrue statement or omission or alleged untrue statement or omission in a
registration statement or prospectus that is made in reliance on and in
conformity with written information furnished to the Company by or on behalf of
such Investor Indemnified Party, or (B) conduct by such Investor Indemnified
Party that is found to be fraud or willful misconduct in a non-appealable, final
judgment.
(b) If the indemnification provided for in Section 7.12(a) above
for any reason is held by a court of competent jurisdiction to be unavailable to
an Investor Indemnified Party in respect of any Losses referred to therein, then
the Company, in lieu of indemnifying such Investor Indemnified Party thereunder,
shall contribute to the amount paid or payable by such Investor Indemnified
Party as a result of such Losses (i) in such proportion as is appropriate to
reflect the relative benefits received by the Company and the Investors, or (ii)
if the allocation provided by clause (i) above is not permitted by applicable
law then in such proportion as is appropriate to reflect not only the relative
benefits referred to in clause (i) above but also the
16
relative fault of the Company and the Investors in connection with the action or
inaction which resulted in such Losses, as well as any other relevant equitable
considerations. The relative fault of the Company and the Investors shall be
determined by reference to, among other things, whether the untrue or alleged
untrue statement of a material fact or the omission or alleged omission to state
a material fact relates to information supplied by the Company and the Investors
and the parties' relative intent, knowledge, access to information and
opportunity to correct or prevent such statement or omission.
(c) Each of the Company and the Investors agrees that it would not
be just and equitable if contribution pursuant to Section 7.12(b) were
determined by pro rata or per capita allocation or by any other method of
allocation which does not take account of the equitable considerations referred
to in the immediately preceding paragraph.
7.13. TERM. Except as provided below, the covenants set forth in this
Section VII shall terminate upon the closing of a Qualified Public Offering.
Notwithstanding the foregoing, the covenants set forth in Sections 7.5 and 7.7
hereof shall continue for so long as any Investor Nominee is a member of the
Board of Directors, and the covenants set forth in Sections 7.12 hereof shall
continue until the expiration of the applicable statute of limitations.
SECTION VIII. MISCELLANEOUS PROVISIONS
8.1. RELIANCE. Each of the parties hereto agrees that each
representation, warranty, covenant and agreement made by it in this Agreement or
in any certificate, instrument or other document delivered pursuant to this
Agreement is material, shall be deemed to have been relied upon by the other
parties and shall remain operative and in full force and effect after the date
hereof regardless of any investigation. This Agreement shall not be construed so
as to confer any right or benefit upon any Person other than the parties hereto
and their respective successors and permitted assigns to the extent contemplated
herein.
8.2. LEGEND ON SECURITIES. The Company and the Stockholders acknowledge
and agree that in addition to any other legend on the certificates representing
Shares held by them, substantially the following legend shall be typed on each
certificate evidencing any of the Shares held at any time by any of the
Stockholders:
THE SECURITIES REPRESENTED HEREBY ARE SUBJECT TO THE PROVISIONS OF A
CERTAIN STOCKHOLDERS AGREEMENT, DATED AS OF SEPTEMBER 30, 2003, INCLUDING
CERTAIN RESTRICTIONS ON TRANSFER SET FORTH THEREIN. A COMPLETE AND CORRECT
COPY OF SUCH AGREEMENT IS AVAILABLE FOR INSPECTION AT THE PRINCIPAL OFFICE
OF THE COMPANY AND WILL BE FURNISHED UPON WRITTEN REQUEST AND WITHOUT
CHARGE.
8.3. AMENDMENT AND WAIVER; ACTIONS OF THE BOARD. Any party may waive any
provision hereof intended for its benefit in writing. No failure or delay on the
part of any party hereto in exercising any right, power or remedy hereunder
shall operate as a waiver thereof. The
17
remedies provided for herein are cumulative and are not exclusive of any
remedies that may be available to any party hereto at law or in equity or
otherwise. This Agreement may be amended with the prior written consent of the
Company and a Majority Interest, provided, however, that any such amendment that
adversely affects the Existing Stockholders shall require a prior written
consent of a majority-in-interest of the Existing Stockholders (based upon the
number of Shares held by each Existing Stockholder). Any consent given as
provided in the preceding sentence shall be binding on all Stockholders.
8.4. NOTICES. All notices and other communications provided for herein
shall be in writing and shall be deemed to have been duly given, delivered and
received (a) if delivered personally or (b) if sent by facsimile, registered or
certified mail (return receipt requested) postage prepaid, or by courier
providing next day delivery, in each case to the party to whom it is directed,
which if to the Company, shall be at Eagle Test Systems, 620 S. Butterfield
Road, Mundelein, Illinois 60060-4483, and if to any Investor or Existing
Stockholder, at the addresses set forth below such party's signature hereto (or
at such other address for any party as shall be specified by notice given in
accordance with the provisions hereof, provided that notices of a change of
address shall be effective only upon receipt thereof). Notices delivered
personally shall be effective on the day so delivered, notices sent by
registered or certified mail shall be effective five days after mailing, notices
sent by facsimile shall be effective when receipt is acknowledged, and notices
sent by courier providing next day delivery shall be effective on the earlier of
the second business day after timely deposit with the courier or the day of
actual delivery by the courier.
8.5. HEADINGS. The Section headings used or contained in this Agreement
are for convenience of reference only and shall not affect the construction of
this Agreement. The parties have participated jointly in the negotiation and
drafting of this Agreement and the other agreements, documents and instruments
executed and delivered in connection herewith with counsel sophisticated in
investment transactions. In the event an ambiguity or question of intent or
interpretation arises, this Agreement and the agreements, documents and
instruments executed and delivered in connection herewith shall be construed as
if drafted jointly by the parties and no presumption or burden of proof shall
arise favoring or disfavoring any party by virtue of the authorship of any
provisions of this Agreement and the agreements, documents and instruments
executed and delivered in connection herewith.
8.6. COUNTERPARTS. This Agreement may be executed in one or more
counterparts and by the parties hereto in separate counterparts, each of which
when so executed shall be deemed to be an original and all of which together
shall be deemed to constitute one and the same agreement.
8.7. ENTIRE AGREEMENT. This Agreement, together with the other
Transaction Documents, is intended by the parties as a final expression of their
agreement and intended to be complete and exclusive statement of the agreement
and understanding of the parties hereto in respect of the subject matter
contained herein.
18
8.8. LAW GOVERNING. This Agreement shall be construed and enforced in
accordance with and governed by the laws of the Illinois (without giving effect
to principles of conflicts of law).
8.9. SUCCESSORS AND ASSIGNS. This Agreement shall be binding upon and
inure to the benefit of the respective successors and permitted assigns of the
parties hereto as contemplated herein, and any successor to the Company by way
of merger or otherwise shall specifically agree to be bound by the terms hereof
as a condition of such successor. The rights of the Investors hereunder shall be
binding upon and inure to the benefit of their Transferees of their Shares as
contemplated herein. This Agreement may not be assigned by any Existing
Stockholder except as provided herein, and any such attempted Transfer that is
not as provided herein shall be null and void.
8.10. DISPUTE RESOLUTION. All disputes, claims, or controversies arising
out of or relating to this Agreement, or any other agreement executed and
delivered pursuant to this Agreement, or the negotiation, validity or
performance hereof and thereof or the transactions contemplated hereby, that are
not resolved by mutual agreement shall be resolved in accordance with the
provisions set forth in Sections 6.7 and 6.8 of the Purchase Agreement.
8.11. REMEDIES; SEVERABILITY. Notwithstanding Section 8.10 above, it is
specifically understood and agreed that any breach of the provisions of this
Agreement, or any other agreement executed and delivered pursuant to this
Agreement, by any person subject hereto will result in irreparable injury to the
other parties hereto, that the remedy at law alone will be an inadequate remedy
for such breach, and that, in addition to any other remedies which they may
have, such other parties may enforce their respective rights by actions for
specific performance (to the extent permitted by law). Whenever possible, each
provision of this Agreement shall be interpreted in such a manner as to be
effective and valid under applicable law, but if any provision of this Agreement
shall be deemed prohibited or invalid under such applicable law, such provision
shall be ineffective to the extent of such prohibition or invalidity, and such
prohibition or invalidity shall not invalidate the remainder of such provision
or the other provisions of this Agreement.
8.12. TERMINATION. Sections III, IV, V and VI shall terminate upon a
Qualified Public Offering.
8.13. CONFIDENTIALITY. Notwithstanding anything herein or any other
express or implied agreement, arrangement or understanding to the contrary, the
parties acknowledge and agree that (i) any obligations of confidentiality
contained herein and therein do not apply and have not applied from the
commencement of discussions between the parties to the tax treatment and tax
structure of the transactions contemplated by this Agreement (and any related
transactions or agreements) and (ii) each party to this Agreement (and each of
its employees, representatives or other agents) may disclose to any and all
persons, without limitation of any kind, the tax treatment and tax structure of
the transactions contemplated by this Agreement and all materials of any kind
(including opinions or other tax analyses) that are provided to it relating to
such tax treatment and tax structure. This authorization to disclose the tax
treatment and tax structure is
19
limited to the extent that confidentiality is required to comply with any
applicable securities laws.
[SIGNATURE PAGE FOLLOWS]
20
IN WITNESS WHEREOF, the parties hereto have caused this Stockholders
Agreement to be duly executed as of the date first set forth above.
THE COMPANY:
EAGLE TEST SYSTEMS, INC.
By: /s/ Leonard Foxman
----------------------------------------
Name: Leonard Foxman
Title: President
EXISTING STOCKHOLDERS:
LEONARD FOXMAN
By: /s/ Leonard Foxman
----------------------------------------
Leonard Foxman
Address for Notice:
1929 Browning Ct.
Highland Park, IL 60035
FOXMAN FAMILY, LLC
By: /s/ Leonard Foxman
----------------------------------------
Leonard Foxman
Its: Manager
Address for Notice:
1929 Browning Ct.
Highland Park, IL 60035
EAGLE TEST SYSTEMS, INC.
EMPLOYEE STOCK OWNERSHIP PLAN
By: /s/ Leonard Foxman
----------------------------------------
Leonard Foxman, not in his individual
capacity or in his capacity as shareholder,
director or officer of the Corporation, but
solely as trustee of the Eagle Test Systems
Employee Stock Ownership Plan
Address for Notice:
1929 Browning Ct.
Highland Park, IL 60035
JACK WEIMER
By: /s/ Jack Weimer
----------------------------------------
Jack Weimer
Address for Notice:
646 N. Lake St.
Grayslake, IL 60030
STEVE DOLLENS
By: /s/ Steve Dollens
----------------------------------------
Steve Dollens
Address for Notice:
3591 Pine Ridge Way
San Jose, CA 95127
INVESTORS:
TA IX L.P.
By: TA Associates IX LLC, its General Partner
By: TA Associates, Inc., its Manager
By: /s/ Michael C. Child
----------------------------------------
Name: Michael C. Child
Title:Managing Director
TA/ATLANTIC AND PACIFIC IV L.P.
By: TA Associates AP IV L.P., its General Partner
By: TA Associates, Inc., its General Partner
By: /s/ Michael C. Child
----------------------------------------
Name: Michael C. Child
Title:Managing Director
TA STRATEGIC PARTNERS FUND A L.P.
By: TA Associates SPF L.P., its General Partner
By: TA Associates, Inc., its General Partner
By: /s/ Michael C. Child
----------------------------------------
Name:Michael C. Child
Title:Managing Director
TA STRATEGIC PARTNERS FUND B L.P.
By: TA Associates SPF L.P., its General Partner
By: TA Associates, Inc., its General Partner
By: /s/ Michael C. Child
----------------------------------------
Name: Michael C. Child
Title:Managing Director
TA INVESTORS LLC
By: TA Associates, Inc., its Manager
By: /s/ Michael C. Child
----------------------------------------
Name: Michael C. Child
Title:Managing Director
TA SUBORDINATED DEBT FUND, L.P.
By: TA Associates SDF LLC, its General Partner
By: TA Associates, Inc., its Manager
By: /s/ Michael C. Child
----------------------------------------
Name: Michael C. Child
Title:Managing Director
Address for Notice
(including those
investors listed
above):
Attn: Michael C. Child and Jameson J. McJunkin
125 High Street
Suite 2500
Boston, MA 02110
EXHIBIT A
Form of Joinder Agreement
The undersigned hereby agrees, effective as of the date hereof, to
become a party to that certain Stockholders Agreement (the "Agreement") dated as
of September 30, 2003, by and among Eagle Test Systems, Inc. (the "Company") and
the parties named therein and for all purposes of the Agreement, the undersigned
shall be included within the term ["EXISTING STOCKHOLDER"/"INVESTOR"] (as
defined in the Agreement). The undersigned further confirms that the
representations and warranties contained in Section II of the Agreement are true
and correct as to the undersigned as of the date hereof. The address and
facsimile number to which notices may be sent to the undersigned is as follows:
Facsimile No.
----------------------
--------------------------------
[NAME OF UNDERSIGNED]
EXHIBIT B
Form of Employee Nondisclosure, Noncompetition and Assignment Agreement
EAGLE TEST SYSTEMS, INC.
EMPLOYEE CONFIDENTIALITY AND ASSIGNMENT AGREEMENT
In consideration and as a condition of my employment or continued
employment by Eagle Test Systems, Inc. (the "Company"), I agree as follows:
1. PROPRIETARY INFORMATION. I agree that all information, whether or not in
writing, concerning the Company's business, technology, business relationships
or financial affairs which the Company has not released to the general public
(collectively, "Proprietary Information") is and will be the exclusive property
of the Company. By way of illustration, Proprietary Information may include
information or material which has not been made generally available to the
public, such as: (a) corporate information, including plans, strategies,
methods, policies, resolutions, negotiations or litigation; (b) marketing
information, including strategies, methods, customer identities or other
information about customers, prospect identities or other information about
prospects, or market analyses or projections; (c) financial information,
including cost and performance data, debt arrangements, equity structure,
investors and holdings, purchasing and sales data and price lists; and (d)
operational and technological information, including plans, specifications,
manuals, forms, templates, software, designs, procedures, formulas, discoveries,
inventions, improvements, concepts and ideas; and (e) personnel information,
including personnel lists, reporting or organizational structure, resumes,
personnel data, compensation structure, performance evaluations and termination
arrangements or documents. Proprietary Information also includes information
received in confidence by the Company from its customers or suppliers or other
third parties.
2. RECOGNITION OF COMPANY'S RIGHTS. I hereby confirm that I have not disclosed
any Proprietary Information previously disclosed to me to anyone outside of the
Company or used or permitted to be used any Proprietary Information previously
disclosed to me for any purpose other than the performance of my duties as an
employee of the Company. I will not, at any time, without the Company's prior
written permission, either during or after my employment, disclose any
Proprietary Information to anyone outside of the Company, or use or permit to be
used any Proprietary Information for any purpose other than the performance of
my duties as an employee of the Company. I will cooperate with the Company and
use my best efforts to prevent the unauthorized disclosure of all Proprietary
Information. I will deliver to the Company all copies of Proprietary Information
in my possession or control upon the earlier of a request by the Company or
termination of my employment.
3. RIGHTS OF OTHERS. I understand that the Company is now and may hereafter be
subject to non-disclosure or confidentiality agreements with third persons which
require the Company to protect or refrain from use of proprietary information. I
agree to be bound by the terms of such agreements in the event I have access to
such proprietary information.
4. COMMITMENT TO COMPANY; AVOIDANCE OF CONFLICT OF INTEREST. While an employee
of the Company, I will devote my full-time efforts to the Company's business and
I will not engage in any other business activity that conflicts with my duties
to the Company. I will advise the president of the Company or his or her nominee
at such time as any activity of either the Company or another business presents
me with a conflict of interest or the appearance of a conflict of interest as an
employee of the Company. I will take whatever action is requested of me by the
Company to resolve any conflict or appearance of conflict which it finds to
exist.
5. DEVELOPMENTS. I will make full and prompt disclosure to the Company of all
inventions, discoveries, designs, developments, methods, modifications,
improvements, processes, algorithms, databases, computer programs, formulae,
techniques, trade secrets, graphics or images, audio or visual works, and other
works of authorship (collectively "Developments"), whether or not patentable or
copyrightable, that are created, made, conceived or reduced to practice by me
(alone or jointly with others) or under my direction during the period of my
employment. I acknowledge that all work performed by me is on a "work for hire"
basis, and I acknowledge and confirm that I have assigned and transferred,
hereby do assign and transfer, and will assign and transfer, to the Company and
its successors and assigns all my right, title and interest in all Developments
that (a) relate to the business of the Company or any customer of or supplier to
the Company or any of the products or services being researched, developed,
manufactured or sold by the Company or which may be used with such products or
services; or (b) result from tasks assigned to me by the Company; or (c) result
from the use of premises or personal property (whether tangible or intangible)
owned, leased or contracted for by the Company ("Company-Related Developments"),
and all related patents, patent applications, trademarks and trademark
applications, copyrights and copyright applications, and other intellectual
property rights in all countries and territories worldwide and under any
international conventions ("Intellectual Property Rights").
To preclude any possible uncertainty, I have set forth on Exhibit A
attached hereto a complete list of Developments that I have, alone or jointly
with others, conceived, developed or reduced to practice prior to the
commencement of my
employment with the Company that I consider to be my property or the property of
third parties and that I wish to have excluded from the scope of this Agreement
("Prior Inventions"). I have also listed on Exhibit A all patents and patent
applications in which I am named as an inventor, other than those which have
been assigned to the Company ("Other Patent Rights"). If no such disclosure is
attached, I represent that there are no Prior Inventions or Other Patent Rights.
If, in the course of my employment with the Company, I incorporate a Prior
Invention into a Company product, process or machine or other work done for the
Company, I hereby grant to the Company a nonexclusive, royalty-free,
irrevocable, worldwide license (with the full right to sublicense) to make, have
made, modify, use and sell such Prior Invention. Notwithstanding the foregoing,
I will not incorporate, or permit to be incorporated, Prior Inventions in any
Company-Related Development without the Company's prior written consent.
This Agreement does not obligate me to assign to the Company any
Development which, in the sole judgment of the Company, reasonably exercised, is
developed entirely on my own time and does not relate to the business efforts or
research and development efforts in which, during the period of my employment,
the Company actually is engaged or reasonably would be engaged, and does not
result from the use of premises or equipment owned or leased by the Company.
However, I will also promptly disclose to the Company any such Developments for
the purpose of determining whether they qualify for such exclusion. I understand
that to the extent this Agreement is required to be construed in accordance with
the laws of any state which precludes a requirement in an employee agreement to
assign certain classes of inventions made by an employee, this paragraph 5 will
be interpreted not to apply to any invention which a court rules and/or the
Company agrees falls within such classes. I also hereby waive all claims to any
moral rights or other special rights which I may have or accrue in any
Company-Related Developments.
6. DOCUMENTS AND OTHER MATERIALS. I will keep and maintain adequate and current
records of all Proprietary Information and Company-Related Developments
developed by me during my employment, which records will be available to and
remain the sole property of the Company at all times.
All files, letters, notes, memoranda, reports, records, data, sketches,
drawings, notebooks, layouts, charts, quotations and proposals, specification
sheets, program listings, blueprints, models, prototypes, or other written,
photographic or other tangible material containing Proprietary Information,
whether created by me or others, which come into my custody or possession, are
the exclusive property of the Company to be used by me only in the performance
of my duties for the Company. Any property situated on the Company's premises
and owned by the Company, including without limitation computers, disks and
other storage media, filing cabinets or other work areas, is subject to
inspection by the Company at any time with or without notice. In the event of
the termination of my employment for any reason, I will deliver to the Company
all files, letters, notes, memoranda, reports, records, data, sketches,
drawings, notebooks, layouts, charts, quotations and proposals, specification
sheets, program listings, blueprints, models, prototypes, or other written,
photographic or other tangible material containing Proprietary Information, and
other materials of any nature pertaining to the Proprietary Information of the
Company and to my work, and will not take or keep in my possession any of the
foregoing or any copies.
7. ENFORCEMENT OF INTELLECTUAL PROPERTY RIGHTS. I will cooperate fully with the
Company, both during and after my employment with the Company, with respect to
the procurement, maintenance and enforcement of Intellectual Property Rights in
Company-Related Developments. I will sign all papers, including without
limitation copyright applications, patent applications, declarations, oaths,
assignments of priority rights, and powers of attorney, which the Company may
deem necessary or desirable in order to protect its rights and interests in any
Company-Related Development. If the Company is unable, after reasonable effort,
to secure my signature on any such papers, I hereby irrevocably designate and
appoint each officer of the Company as my agent and attorney-in-fact to execute
any such papers on my behalf, and to take any and all actions as the Company may
deem necessary or desirable in order to protect its rights and interests in any
Company-Related Development.
8. NON-COMPETITION AND NON-SOLICITATION. I understand and acknowledge that
Company's market for its existing and/or proposed products is worldwide. I also
understand and acknowledge that the competitors for Company's existing and
proposed products are located worldwide and that geographic boundaries do not
define the scope of competition in this field. Further, I understand and
acknowledge that, during the course of my employment with Company, I will be
given access to and will help develop Proprietary Information, which if such
Proprietary Information were released to the general public or to a competitor,
would place Company at a disadvantage with its competitors. Therefore, in order
to protect the Company's Proprietary Information and good will, during my
employment and for a period of twelve (12) months following the termination of
my employment for any reason (the "Restricted Period"), I will not engage in any
activity that is or is intended to be, directly or indirectly competitive with
those aspects of the Company business with which I was concerned or with respect
to which I had access to Proprietary Information during my employment with the
Company.] In addition, during the Restricted Period, I will not, directly or
indirectly, in any manner, other than for the benefit of the Company, (a) call
upon, solicit, divert or take away any of the customers, business or prospective
customers of the Company or any of its suppliers, and/or (b) solicit, entice or
attempt to persuade any other employee or consultant of the Company to leave the
services of the Company for any reason. I acknowledge and agree that if I
violate any of the provisions of this paragraph 8, the running of the Restricted
Period will be extended by the tie during which I engage in such violation(s).
9. GOVERNMENT CONTRACTS. I acknowledge that the Company may have from time to
time agreements with other persons or with the United States Government or its
agencies
which impose obligations or restrictions on the Company regarding inventions
made during the course of work under such agreements or regarding the
confidential nature of such work. I agree to comply with any such obligations or
restrictions upon the direction of the Company. In addition to the rights
assigned under paragraph 5, I also assign to the Company (or any of its
nominees) all rights which I have or acquired in any Developments, full title to
which is required to be in the United States under any contract between the
Company and the United States or any of its agencies.
10. PRIOR AGREEMENTS. I hereby represent that, except as I have fully disclosed
previously in writing to the Company, I am not bound by the terms of any
agreement with any previous employer or other party to refrain from using or
disclosing any trade secret or confidential or proprietary information in the
course of my employment with the Company or to refrain from competing, directly
or indirectly, with the business of such previous employer or any other party. I
further represent that my performance of all the terms of this Agreement as an
employee of the Company does not and will not breach any agreement to keep in
confidence proprietary information, knowledge or data acquired by me in
confidence or in trust prior to my employment with the Company. I will not
disclose to the Company or induce the Company to use any confidential or
proprietary information or material belonging to any previous employer or
others.
11. REMEDIES UPON BREACH. I understand that the restrictions contained in this
Agreement are necessary for the protection of the business and goodwill of the
Company and I consider them to be reasonable for such purpose. Any breach of
this Agreement is likely to cause the Company substantial and irrevocable damage
and therefore, in the event of such breach, the Company, in addition to such
other remedies which may be available, will be entitled to specific performance
and other injunctive relief.
12. PUBLICATIONS AND PUBLIC STATEMENTS. I will obtain the Company's written
approval before publishing or submitting for publication any material that
relates to my work at the Company and/or incorporates any Proprietary
Information. To ensure that the Company delivers a consistent message about its
products, services and operations to the public, and further in recognition that
even positive statements may have a detrimental effect on the Company in certain
securities transactions and other contexts, any statement about the Company
which I create, publish or post during my period of employment and for six (6)
months thereafter, on any media accessible by the public, including but not
limited to electronic bulletin boards and Internet-based chat rooms, must first
be reviewed and approved by an officer of the Company before it is released in
the public domain.
13. NO EMPLOYMENT OBLIGATION. I understand that this Agreement does not create
an obligation on the Company or any other person to continue my employment. I
acknowledge that, unless otherwise agreed in a formal written employment
agreement signed on behalf of the Company by an authorized officer, my
employment with the Company is at will and therefore may be terminated by the
Company or me at any time and for any reason.
14. SURVIVAL AND ASSIGNMENT BY THE COMPANY. I understand that my obligations
under this Agreement will continue in accordance with the its express terms
regardless of any changes in my title, position, duties, salary, compensation or
benefits or other terms and conditions of employment. I further understand that
my obligations under this Agreement will continue following the termination of
my employment regardless of the manner of such termination and will be binding
upon my heirs, executors and administrators. The Company will have the right to
assign this Agreement to its affiliates, successors and assigns. I expressly
consent to be bound by the provisions of this Agreement for the benefit of the
Company or any parent, subsidiary or affiliate to whose employ I may be
transferred without the necessity that this Agreement be resigned at the time of
such transfer.
15. DISCLOSURE TO FUTURE EMPLOYERS. I will provide a copy of this Agreement to
any prospective employer, partner or coventurer prior to entering into an
employment, partnership or other business relationship with such person or
entity.
16. SEVERABILITY. In case any provisions (or portions thereof) contained in this
Agreement shall, for any reason, be held invalid, illegal or unenforceable in
any respect, such invalidity, illegality or unenforceability shall not affect
the other provisions of this Agreement, and this Agreement shall be construed as
if such invalid, illegal or unenforceable provision had never been contained
herein. If, moreover, any one or more of the provisions contained in this
Agreement shall for any reason be held to be excessively broad as to duration,
geographical scope, activity or subject, it shall be construed by limiting and
reducing it, so as to be enforceable to the extent compatible with the
applicable law as it shall then appear.
17. INTERPRETATION. This Agreement will be deemed to be made and entered into in
the State of Illinois, and will in all respects be interpreted, enforced and
governed under the laws of the State of Illinois. I hereby agree to consent to
personal jurisdiction of the state and federal courts situated within Cook
County, Illinois for purposes of enforcing this Agreement, and waive any
objection that I might have to personal jurisdiction or venue in those courts.
I UNDERSTAND THAT THIS AGREEMENT AFFECTS IMPORTANT RIGHTS. BY SIGNING
BELOW, I CERTIFY THAT I HAVE READ IT CAREFULLY AND AM SATISFIED THAT I
UNDERSTAND IT COMPLETELY.
IN WITNESS WHEREOF, the undersigned has executed this agreement as a
sealed instrument as of the date set forth below.
Signed: __________________________________________________________
(Employee's full name)
Type or print name: _____________________
Social Security Number: ________________ Date: __________________
EXHIBIT A
To: Eagle Test Systems, Inc.
From:
-----------------------
Date:
-----------------------
SUBJECT: PRIOR INVENTIONS
The following is a complete list of all inventions or improvements
relevant to the subject matter of my employment by the Company that have been
made or conceived or first reduced to practice by me alone or jointly with
others prior to my engagement by the Company:
/ / No inventions or improvements
/ / See below:
--------------------------------------------------------------
--------------------------------------------------------------
--------------------------------------------------------------
/ / Additional sheets attached
The following is a list of all patents and patent applications in which
I have been named as an inventor:
/ / None
/ / See below:
--------------------------------------------------------------
--------------------------------------------------------------
--------------------------------------------------------------
SCHEDULE A
Existing Stockholders and Investors
STOCKHOLDERS:
SHARES OF COMMON
NAME STOCK
---- -----
Leonard Foxman 2,928.864
Foxman Family, LLC 1,847.000
Eagle Test Systems, Inc. Employee Stock 890.204
Ownership Plan
Jack Weimer 81.758
Steve Dollens 8.174
INVESTORS:
SHARES OF SERIES A
CONVERTIBLE
NAME INVESTMENT AMOUNT PREFERRED STOCK
---- ----------------- ---------------
TA IX L.P. $48,999,999.71 2,590.290
TA/Atlantic and Pacific IV L.P. $13,836,996.54 731.466
TA Strategic Partners Fund A L.P. $1,003,006.61 53.022
TA Strategic Partners Fund B L.P. $179,993,36 9.515